|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense), net | ||
| Interest income | ||
| Other expense | ||
| Total other income (expense), net | ||
| Net loss | ||
| Other comprehensive loss: | ||
| Unrealized gains (losses) on marketable securities | ||
| Total other comprehensive income (loss) | ||
| Comprehensive loss | ||
| Accretion of redeemable convertible preferred stock to redemption value | ||
| Net loss attributable to common stockholders | ||
| Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) | ||
| Weighted average common shares outstanding, basic and diluted (in shares) |
Loading...
